Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Pharmacia & Upjohn's Nasalcrom

This article was originally published in The Tan Sheet

Executive Summary

Pharmacia & Upjohn's Nasalcrom: Pharmacist education program to be introduced in late July to help promote the OTC cromolyn sodium allergy treatment and prevention product, Pharmacia & Upjohn Consumer Healthcare announces July 2. More than 60,000 mailings to pharmacists will convey "basic allergy information and Nasalcrom product education, including its prevention benefit, unique mode of action and excellent safety profile," P&U says. The mailing is part of an overall effort that includes advertising in trade journals and participation in fall pharmacy conventions. Pharmacia & Upjohn, which recently acquired Nasalcrom from J&J's McNeil Consumer, is relaunching the product this fall with increased marketing support. Advertising will be handled by Jordan McGrath Case & Taylor ("The Tan Sheet" June 23, p. 1)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087269

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel